Economy · World

THEON Acquires French HGH to Strengthen Electro-Optical Systems Presence

3 sourcesFirst reported 1 month agoUpdated 1 month ago

Story Compare

AI summary: catch up in 20 seconds

THEON has reached an exclusive agreement to acquire HGH Systèmes Infrarouges.
The acquisition is valued at approximately €300 million and enhances THEON's product portfolio.
HGH specializes in electro-optical and infrared systems for defense and civilian applications.
This move is part of THEON's strategy to establish itself as a leader in the sector.
The acquisition is anticipated to significantly increase THEON's revenue and profitability.

Generated by AI from the 3 sources below · always verify with the originals

AI summary: catch up in 20 seconds

Summarising the coverage…

Generated by AI from the 3 sources below · always verify with the originals

The full picture

AI-synthesised from 3 sources · no editorial bias

Theon International (THEON) has announced an exclusive agreement to acquire HGH Systèmes Infrarouges, a French company, as part of its strategy to expand into electro-optical solutions for various platforms. The deal involves the purchase of Steropes SAS, the parent company of HGH, and is valued at approximately €300 million. This acquisition is expected to enhance THEON's presence in the electro-optics sector.

The agreement was made with Carlyle Europe Technology Partners, which currently owns HGH. By integrating HGH's expertise and technologies, THEON aims to strengthen its portfolio and market position in the electro-optical systems industry. The deal signifies a significant step in THEON's efforts to broaden its offerings and capabilities in this rapidly evolving field.

The full picture

AI-synthesised from 3 sources · no editorial bias

Synthesis generating…

THEON Acquires French HGH to Strengthen Electro-Optical Systems Presence

All coverage (3)

Comments · 0 (subscribers)